Search results for: 'Simulation manufacturing'

The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies towa...

With this research service, Frost & Sullivan’s Healthcare and Life Sciences team provides critical insights into the European Union and UK COVID-19 vaccine and therapeutics market. The report analyzes COVID-19 vaccines and therapeutics in development and delves into supply chain considerations and requirements to manage distribution. Importantly, t...

10 Jan 2017  |  Europe  |  Market Research

Custom Procedure Trays and Packs in Western and Eastern Europe, Forecast to 2021

With Heavy Commoditization and Low-cost Manufacturing, Product-driven Business Models are Transitioning to Service-driven Models

Infographics

×

This research service presents a detailed analysis of the European Custom Procedure Trays and Packs (CPTP) market. It provides an in-depth analysis of the market size, revenue forecast, overall as well as by surgical custom procedure trays and packs and minor procedure trays and packs and by packaging type (boxes, wraps and moulds). The surgical se...

20 Feb 2020  |  Europe  |  Market Outlook

EU Healthcare Predictions and Outlook, 2020

Rise in Orphan Drug R&D Pipeline, AI-based Funding, and Growth in Biocontract Manufacturing to be Key Drivers of Growth

Infographics

×

Amid rising global trade tensions and sluggish global economic outlook for 2020, the global healthcare market is expected to cross the 2-trillion-dollar mark in 2020. In Europe, BREXIT is likely to have a strong impact on the United Kingdom, Europe's biggest digital health market. 2020 will be a global reality check for long-pending national health...

Patent expiration and increased use of traditional generic drugs are leading to a shift of focus in the pharmaceutical industry toward investment in specialty drugs and high growth areas such as biosimilars. Expensive biopharmaceuticals are largely used for life-saving disorders such as cancer and diabetes, the incidence of which is increasing with...

This study examines the Turkish medical imaging market. Healthcare reforms focusing on oncology and cardiology as the priority areas has resulted in 80% of medical imaging equipment being purchased by the government. Frost & Sullivan estimates that revenue for computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound (USG) will rea...

This strategic analysis service provides detailed analysis of European therapeutic peptide market and includes segmentation on the basis of customer base and therapeutic categories. The service in PowerPoint format focuses not just only on the peptide markets but also on strategies for differentiation amongst therapeutic peptide suppliers/manufactu...

Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...

This research service profiles 51 of the major players within the European medical devices industry, detailing the market segments they cover, the devices they produce, their global locations, aspects relating to manufacture, distribution and OEM services within the company and their future plans. The research service may highlight areas for possib...